Express Scripts Holding Co

Find Ratings Reports
ESRX : NASDAQ : Health Care
$64.84 | %
Today's Range: 0.0 - 0.0
Avg. Daily Volume: 4313600.0
03/28/17 - 4:00 PM ET

Financial Analysis


EXPRESS SCRIPTS HOLDING CO's gross profit margin for the fourth quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales decreased, the net income has increased. EXPRESS SCRIPTS HOLDING CO has weak liquidity. Currently, the Quick Ratio is 0.62 which shows a lack of ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.

During the same period, stockholders' equity ("net worth") has decreased by 6.54% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY16 Q4 FY15
Net Sales ($mil)24863.326175.4
EBITDA ($mil)1962.72000.5
EBIT ($mil)1474.71392.8
Net Income ($mil)1434.7773.5


Balance Sheet Q4 FY16 Q4 FY15
Cash & Equiv. ($mil)3077.23186.3
Total Assets ($mil)51744.953243.3
Total Debt ($mil)15568.315592.7
Equity ($mil)16236.017372.8


Profitability Q4 FY16 Q4 FY15
Gross Profit Margin9.529.08
EBITDA Margin7.897.64
Operating Margin5.935.32
Sales Turnover1.941.91
Return on Assets6.574.65
Return on Equity20.9614.25
Debt Q4 FY16 Q4 FY15
Current Ratio0.750.7
Debt/Capital0.490.47
Interest Expense146.0123.2
Interest Coverage10.111.31


Share Data Q4 FY16 Q4 FY15
Shares outstanding (mil)605.5676.9
Div / share0.00.0
EPS2.341.13
Book value / share26.8125.67
Institutional Own % n/a n/a
Avg Daily Volume4168371.04200054.0

Valuation


HOLD. EXPRESS SCRIPTS HOLDING CO's P/E ratio indicates a significant discount compared to an average of 26.92 for the Health Care Providers & Services industry and a significant discount compared to the S&P 500 average of 26.33. For additional comparison, its price-to-book ratio of 2.39 indicates a discount versus the S&P 500 average of 2.93 and a discount versus the industry average of 3.32. The current price-to-sales ratio is well below the S&P 500 average and is also below the industry average, indicating a discount. Upon assessment of these and other key valuation criteria, EXPRESS SCRIPTS HOLDING CO proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ESRX 11.79 Peers 26.92   ESRX 7.88 Peers 12.27

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

ESRX is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ESRX is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ESRX 8.39 Peers 15.47   ESRX 0.41 Peers 1.24

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

ESRX is trading at a significant discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ESRX trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ESRX 2.39 Peers 3.32   ESRX 51.67 Peers 20.20

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ESRX is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

ESRX is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ESRX 0.39 Peers 0.85   ESRX -1.44 Peers 11.72

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ESRX is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ESRX significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades